RT journal article T1 Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies A1 de Mendoza, Carmen A1 Pérez, Leire A1 Fernández-Ruiz, Mario A1 Pena, María José A1 Ramos, José Manuel A1 Richart, Alberto A1 Piron, María A1 Rando, Ariadna A1 Miró, Elisenda A1 Reina, Gabriel A1 Encinas, Beatriz A1 Rojo, Silvia A1 Rodríguez Iglesias, Manuel Antonio A1 Benito, Rafael A1 Aguilera, Antonio A1 Treviño, Ana A1 Corral, Octavio A1 Soriano, Vicente A2 BiomedicinaBiotecnología y Salud Pública K1 HTLV-1 K1 Myelopathy Diagnosis K1 Late presentation K1 Sexually transmitted infections AB Objectives: Although only 10% of persons infected with human T-lymphotropic virus type 1 (HTLV-1) may develop virus-associated illnesses over their lifetime, missing the earlier diagnosis of asymptomatic carriers frequently leads to late presentation. Methods: A nationwide HTLV-1 register was created in Spain in 1989. We examined the main demographics and clinical features at the time of the first diagnosis for more than three decades. Results: A total of 428 individuals infected with HTLV-1 had been reported in Spain until the end of 2021. Up to 96 (22%) individuals presented clinically with HTLV-1-associated conditions, including subacute myelopathy (57%), T-cell lymphoma (34%), or Strongyloides stercoralis infestation (8%). Since 2008, HTLV-1 diagnosis has been made at blood banks (44%) or clinics (56%). Native Spaniards and Sub-Saharan Africans are overrepresented among patients presenting with HTLV-1-associated illnesses suggesting that poor epidemiological and/or clinical suspicion, which led to the late presentation are more frequent in them than carriers from Latin America (LATAM) (31.7% vs 20.4%, respectively; P = 0.015). Conclusion: HTLV-1 infection in Spain is frequently diagnosed in patients presenting with characteristic illnesses. Although screening in blood banks mostly identifies asymptomatic carriers from LATAM, a disproportionately high number of Spaniards and Africans are diagnosed too late at the time of clinical manifestations. Expanding testing to all pregnant women and clinics for sexually transmitted infections could help to unveil HTLV-1 asymptomatic carriers. (c) 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ) PB ELSEVIER SN 1201-9712 YR 2022 FD 2022-09 LK http://hdl.handle.net/10498/28007 UL http://hdl.handle.net/10498/28007 LA eng DS Repositorio Institucional de la Universidad de Cádiz RD 17-nov-2026